https://www.zerohedge.com/medical/fda-finally-approved-alzheimers-drug-everything-surrounding-it-controversial https://patents.google.com/patent/US9670272B2/en Aduhelm is the brand name under which the Alzheimer’s drug Aducanumab is marketed. It is developed by the U.S. company Biogen. The drug is to be administered as an intra-venous infusion every four weeks. The Food and Drug Administration (FDA) approved Aducanumab in June 2021, making it the first Alzheimer’s disease medication approved … Continue reading FDA Finally Approved An Alzheimer’s Drug… But Everything Surrounding It Is Controversial | ZeroHedge (Abomination Shots Continue.. MOB Adverse Event)..